2020
DOI: 10.1016/j.exer.2020.108072
|View full text |Cite
|
Sign up to set email alerts
|

Dichloroacetate prevents TGFβ-induced epithelial-mesenchymal transition of retinal pigment epithelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 68 publications
2
17
0
Order By: Relevance
“…The PI3K/Akt pathway mediates a broad range of cellular functions, such as cell transformation, migration, proliferation, apoptosis, and gene expression ( Aguilar-Solis et al, 2017 ; Liu et al, 2019 ). During PVR, binding of TGF-β to its receptor activates PI3K, resulting in the phosphorylation of Akt; activated Akt inhibits glycogen synthase kinase 3β (GSK-3β), promoting EMT in RPE cells ( Shukal et al, 2020 ; Zhang et al, 2018a ). Researchers have found that inhibition or knockdown of GSK-3β promotes cell migration and collagen contraction in ARPE-19 cells, while GSK-3β overexpression and PI3K/Akt inhibitor reverse these cellular responses ( Huang et al, 2017 ).…”
Section: Survey Methodologymentioning
confidence: 99%
See 1 more Smart Citation
“…The PI3K/Akt pathway mediates a broad range of cellular functions, such as cell transformation, migration, proliferation, apoptosis, and gene expression ( Aguilar-Solis et al, 2017 ; Liu et al, 2019 ). During PVR, binding of TGF-β to its receptor activates PI3K, resulting in the phosphorylation of Akt; activated Akt inhibits glycogen synthase kinase 3β (GSK-3β), promoting EMT in RPE cells ( Shukal et al, 2020 ; Zhang et al, 2018a ). Researchers have found that inhibition or knockdown of GSK-3β promotes cell migration and collagen contraction in ARPE-19 cells, while GSK-3β overexpression and PI3K/Akt inhibitor reverse these cellular responses ( Huang et al, 2017 ).…”
Section: Survey Methodologymentioning
confidence: 99%
“… Hatanaka et al (2012) reported that PPAR-γ agonist pioglitazone could prevent TGF-β-induced morphological changes and the up-regulation of EMT-related markers in primary monkey RPE cells, through inhibition of the SMAD pathway. Some drugs, including dichloroacetate (DCA) ( Shukal et al, 2020 ), salinomycin (SNC) ( Heffer et al, 2019 ), resveratrol ( Ishikawa et al, 2015 ), protein kinase A inhibitor H89 ( Lyu et al, 2020 ) and heavy chain-hyaluronan/pentraxin3 ( He et al, 2017 ), reportedly inhibit EMT in an in vitro EMT cell model and prevent PVR development by blocking the activation of theTGF-β pathway. Thus, inhibition of EMT by pharmacological agents may be an effective strategy to prevent PVR development.…”
Section: Survey Methodologymentioning
confidence: 99%
“…Moreover, defects in the major energy sensor, AMP-activated protein kinase (AMPK), have been implicated in EMT of RPE [104]. Enhancing mitochondrial respiration using dichloroacetate, a structural analogue of pyruvate, blocked TGFβ2-induced EMT in RPE [105]. High glucose induces both EMT [106] and EndMT [107] in RPE and retinal endothelial cells, respectively, implicating the role of hyperglycaemia-induced metabolic dysfunction.…”
Section: Metabolic Dysfunction and Autophagy In Amdmentioning
confidence: 99%
“…The PI3K/Akt pathway mediates a broad range of cellular functions, such as cell transformation, migration, proliferation, apoptosis, and gene expression (Aguilar-Solis et al 2017;Liu et al 2019). During PVR, binding of TGF-β to its receptor activates PI3K, resulting in the phosphorylation of Akt; activated Akt inhibits glycogen synthase kinase 3β (GSK-3β), promoting EMT in RPE cells (Shukal et al 2020;Zhang et al 2018a). Researchers have found that inhibition or knockdown of GSK-3β promotes cell migration and collagen contraction in ARPE-19 cells, while GSK-3β overexpression and PI3K/Akt inhibitor reverse these cellular responses (Huang et al 2017).…”
Section: Signaling Pathways Of Emtmentioning
confidence: 99%
“…Hatanaka et al (2012) reported that PPAR-γ agonist pioglitazone could prevent TGF-β-induced morphological changes and the upregulation of EMT-related markers in primary monkey RPE cells, through inhibition of the SMAD pathway. Some drugs, including dichloroacetate (DCA) (Shukal et al 2020), salinomycin (SNC) (Heffer et al 2019), resveratrol (Ishikawa et al 2015), protein kinase A inhibitor H89 (Lyu et al 2020) and heavy chain-hyaluronan/pentraxin3 (He et al 2017), reportedly inhibit EMT in an in vitro EMT cell model and prevent PVR development by blocking the activation of theTGF-β pathway. Thus, inhibition of EMT by pharmacological agents may be an effective strategy to prevent PVR development.…”
Section: Interventions Of Rpe Emtmentioning
confidence: 99%